Detalhe da pesquisa
1.
Meta-analysis of Osteopontin splice variants in cancer.
BMC Cancer;
23(1): 373, 2023 Apr 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37095438
2.
Induction of a cytokine storm involves suppression of the Osteopontin-dependent TH1 response.
Immunology;
167(2): 165-180, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35752943
3.
Nanodelivery of Resveratrol-Loaded PLGA Nanoparticles for Age-Related Macular Degeneration.
AAPS PharmSciTech;
21(8): 291, 2020 Oct 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33085055
4.
Targeting the core program of metastasis with a novel drug combination.
Cancer Med;
13(11): e7291, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38826119
5.
Osteopontin induces mitochondrial biogenesis in deadherent cancer cells.
Oncotarget;
14: 957-969, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38039408
6.
Alterations of Ion Homeostasis in Cancer Metastasis: Implications for Treatment.
Front Oncol;
11: 765329, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34988012
7.
Structural Constraint of Osteopontin Facilitates Efficient Binding to CD44.
Biomolecules;
11(6)2021 05 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34070790
8.
Axitinib-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles for Age-Related Macular Degeneration: Formulation Development and In Vitro Characterization.
Assay Drug Dev Technol;
17(4): 167-177, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31184962